comparemela.com

Latest Breaking News On - Genetic therapy - Page 2 : comparemela.com

Tasked with steadying BIO, Rachel King faces biotech s many challenges

BioPharma

United statesRachel kingMichelle mcmurry heathEnterprise associatesMerck coInflation reduction actWall street journalKorn ferryGenetic therapyNew enterprise associates

World s First Gene Silencing Drug for Alzheimer s Disease & Dementia

World s First Gene Silencing Drug for Alzheimer s Disease & Dementia
medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.

Alzheimers diseaseGenetic therapyEne silencing therapy

ProBioGen Delivers Strong 2022 Performance, Investing for Growth in 2023

BERLIN, Germany, March 30, 2023 / B3C newswire / ProBioGen, the Berlin-based CDMO and technology provider, reported today that revenues for the fiscal year 2022 (FY22) grew 35% vs FY21.In a year marked by new geopolitical and macroeconomic challenges, ProBioGen was able to carry on its rapid growth trajector.

Lutz hilbrichGabriele schneiderSarah wandreyProbiogen press contactManufacturing organizationContract developmentCorporate communicationsChief executive officerBiological productsCell lineGenetic therapy

ProBioGen s Growth Strategy Continues Successfully

Julian Collins, Jana Windt and Michiel Stork Join Biopharma Company’s Leadership TeamBERLIN, Germany, March 02, 2023 / B3C newswire / ProBioGen has seen significant growth with over 300 employees now working across its three locations in Berlin. In line with this growth, three crucial positions have been filled..

Gabriele schneiderJulian collinsJana windtSarah wandreyLutz hilbrichMichiel storkContract developmentHead of marketing communications marcomProbiogen press contactHead of marketing communicationsManufacturing organizationMichiel stork join biopharma company leadership teamCorporate communicationsPeople organizational development departmentHead of people organizational developmentBusiness development

Coriolis Pharma Strengthens its Presence in North America by Appointing Formulation Expert Prof Dr

Prof. Dr. Reza Nejadnik's research at the University of Iowa, College of Pharmacy, is focused on protein pharmaceuticals, their formulation and characterization, and interaction of biologics with interfaces.MARTINSRIED-MUNICH, Germany, February 01, 2023 / B3C newswire / Coriolis Pharma, a globally operating servi.

United statesSilvia steyrer gruberReza nejadnikUniversity of iowaDepartment of pharmaceutical sciencesLeiden academic centerDrug developmentRadboud university nijmegenDrug researchCoriolis pharma research gmbUniversity of texasCollege of pharmacyUniversity of groningenGlobal biologic drug product developmentNorthwestern universityCoriolis pharma

vimarsana © 2020. All Rights Reserved.